Microscan Demonstrates Advanced Technology at Scientific Meeting
By LabMedica International staff writers Posted on 01 Aug 2017 |

Image: The MicroHAWK platform for barcode reading and machine vision (Photo courtesy of Microscan Systems).
Microscan Systems, Inc. (Renton, WA, USA), a provider of embedded clinical barcode readers and machine vision solutions for life sciences, demonstrated advancements of its MicroHAWK platform for barcode reading and machine vision, LVS label verification, and print quality inspection systems at the 69th AACC Annual Scientific Meeting & Clinical Lab Expo, the world’s largest exposition for clinical laboratory products and services.
Microscan’s barcode reading, machine vision, and verification technology serves a wide range of automation and OEM applications and the company’s solutions range from barcode reading, tracking, and traceability to complex machine vision measurement, guidance, barcode verification, and print quality grading. The company was among over 750 exhibitors who displayed pioneering diagnostic technology, including the latest in mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation at the 2017 AACC Clinical Lab Expo held at the San Diego Convention Center from August 1-3.
Microscan’s MicroHAWK platform provides users a single hardware solution with options to meet any barcode decoding or inspection task, in any integration space, and with scalability to meet unique current and future requirements. The hardware has been designed with life science and OEM applications in mind, focused on specific feature customizations in enclosed devices that can be manufactured and supported by Microscan on a long-term basis to accommodate instrument lifecycles.
The company’s miniaturization technology allows medical device manufacturers, laboratories, and OEMs to use MicroHAWK devices in the most space-constrained installations. For instance, the extremely small size of MicroHAWK smart cameras enables them to be easily embedded for automating processes such as specimen and reagent identification, tracking labware presence and absence, cap type and color identification, dimensional measurements such as tube height and diameter, automated alignment and robotic guidance within turnkey medical devices and instruments.
MicroHAWK barcode readers, which were on display at the event, are equipped with Autofocus technology, enabling flexible positioning in medical equipment and other integration environments. MicroHAWK with Autofocus can read symbols at any distance, while fixed-focus models are factory-configured to decode at set focal distances. Autofocus models offer both an automatic autofocus for continuous symbol location and decoding, as well as software-programmable focus - which allows users the option to set fixed focal distances for Autofocus units from Microscan’s Weblink software user interface. Through direct integration of the Autofocus lens technology into MicroHAWK, Microscan eliminates additional cost to the user, minimizes device size, avoids integration complexity and removes the need for additional optical accessories.
Also on display was Microscan’s LVS-9580 Handheld Barcode Verifier - a high-performance handheld solution for off-line barcode verification to ISO/IEC and GS-1 standards. The LVS-9580 reads and analyzes multiple types of linear (1D) and two-dimensional (2D) barcodes up to 3.0 inches (76.19 mm) wide and up to 2.25 inches (57.15 mm) tall, located on a wide range of surfaces. It enables users to test newly designed labels for quality and compliance issues before printing.
Microscan also ran live demonstrations of its LVS-7510 Print Quality Inspection System, configurable into manufacturing lines and printers to check label accuracy on the fly during label printing. It is used for 100% label inspection including 1D/2D barcode verification, OCR, serialization and blemish detection in medical device manufacturing, packaging and other industries. The LVS-7510 identifies errors in code readability and compliance as codes are printed, allowing manufacturers to address printing or formatting issues before incurring fines and scrapped product down the supply chain. Both in-line and off-line verification solutions address the growing need for compliance to the FDA’s Unique Device Identification (UDI) initiative, GS1 and HIBCC data structure, as well as other regulated barcoding and product serialization standards.
Related Links:
Microscan Systems
Microscan’s barcode reading, machine vision, and verification technology serves a wide range of automation and OEM applications and the company’s solutions range from barcode reading, tracking, and traceability to complex machine vision measurement, guidance, barcode verification, and print quality grading. The company was among over 750 exhibitors who displayed pioneering diagnostic technology, including the latest in mobile health, molecular diagnostics, mass spectrometry, point-of-care, and automation at the 2017 AACC Clinical Lab Expo held at the San Diego Convention Center from August 1-3.
Microscan’s MicroHAWK platform provides users a single hardware solution with options to meet any barcode decoding or inspection task, in any integration space, and with scalability to meet unique current and future requirements. The hardware has been designed with life science and OEM applications in mind, focused on specific feature customizations in enclosed devices that can be manufactured and supported by Microscan on a long-term basis to accommodate instrument lifecycles.
The company’s miniaturization technology allows medical device manufacturers, laboratories, and OEMs to use MicroHAWK devices in the most space-constrained installations. For instance, the extremely small size of MicroHAWK smart cameras enables them to be easily embedded for automating processes such as specimen and reagent identification, tracking labware presence and absence, cap type and color identification, dimensional measurements such as tube height and diameter, automated alignment and robotic guidance within turnkey medical devices and instruments.
MicroHAWK barcode readers, which were on display at the event, are equipped with Autofocus technology, enabling flexible positioning in medical equipment and other integration environments. MicroHAWK with Autofocus can read symbols at any distance, while fixed-focus models are factory-configured to decode at set focal distances. Autofocus models offer both an automatic autofocus for continuous symbol location and decoding, as well as software-programmable focus - which allows users the option to set fixed focal distances for Autofocus units from Microscan’s Weblink software user interface. Through direct integration of the Autofocus lens technology into MicroHAWK, Microscan eliminates additional cost to the user, minimizes device size, avoids integration complexity and removes the need for additional optical accessories.
Also on display was Microscan’s LVS-9580 Handheld Barcode Verifier - a high-performance handheld solution for off-line barcode verification to ISO/IEC and GS-1 standards. The LVS-9580 reads and analyzes multiple types of linear (1D) and two-dimensional (2D) barcodes up to 3.0 inches (76.19 mm) wide and up to 2.25 inches (57.15 mm) tall, located on a wide range of surfaces. It enables users to test newly designed labels for quality and compliance issues before printing.
Microscan also ran live demonstrations of its LVS-7510 Print Quality Inspection System, configurable into manufacturing lines and printers to check label accuracy on the fly during label printing. It is used for 100% label inspection including 1D/2D barcode verification, OCR, serialization and blemish detection in medical device manufacturing, packaging and other industries. The LVS-7510 identifies errors in code readability and compliance as codes are printed, allowing manufacturers to address printing or formatting issues before incurring fines and scrapped product down the supply chain. Both in-line and off-line verification solutions address the growing need for compliance to the FDA’s Unique Device Identification (UDI) initiative, GS1 and HIBCC data structure, as well as other regulated barcoding and product serialization standards.
Related Links:
Microscan Systems
Latest AACC 2017 News
- Siemens Healthineers Showcases Atellica Solution at AACC 2017
- Ortho Clinical Diagnostics Highlights Immunodiagnostics at Clinical Expo
- Combating Infectious Diseases Key Focus of AACC
- World's First Fully Integrated LC-MS/MS Clinical Analyzer Unveiled
- Clinical Chemistry Analyzer Provides DAU Screening
- Diatron Displays New Hematology Analyzer at UAE Congress
- AACC Middle East to Be Held in Abu Dhabi
- AACC 2017 Focus on CRISPR and Futuristic Testing Devices
- Opioid Drug Abuse Testing Key Topic at Congress
- Keynote Address to Focus on CRISPR/Cas9 Gene Editing
- Winner of Qualcomm Tricorder XPrize Unveiled at AACC
- Annual Meeting Offers Industry Education and Entertainment
Channels
Clinical Chemistry
view channel
Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
In regions where access to clinics for routine blood tests presents financial and logistical obstacles, HIV patients are increasingly able to collect and send a drop of blood using paper-based devices... Read more
AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more
Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more
Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read moreMolecular Diagnostics
view channel
Portable Blood-Based Device Detects Colon Cancer
Colon cancer is the second leading cause of cancer-related deaths in the U.S., yet it is highly treatable when detected at an early stage. Traditional colonoscopy screenings, although effective, are unpleasant,... Read more
New DNA Test Diagnoses Bacterial Infections Faster and More Accurately
Antimicrobial resistance has emerged as a significant global health threat, causing at least one million deaths annually since 1990. The Global Research on Antimicrobial Resistance (GRAM) Project warns... Read more
Innovative Bio-Detection Platform Improves Early Cancer Screening and Monitoring
Cancer remains one of the leading causes of death globally, underscoring the critical need for more advanced, efficient, and early detection methods. Circulating tumor cells (CTCs) are cells that have... Read more
Blood Test Could Help More Women Survive Aggressive Triple Negative Breast Cancer
Cancer research shows that over 90% of women diagnosed with breast cancer at its earliest stage survive for five years or more. However, this survival rate dramatically decreases to just 30% when the cancer... Read moreHematology
view channel
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
WBC Count Could Predict Severity of COVID-19 Symptoms
The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more
New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors
Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more
Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy
Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read moreImmunology
view channelCerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
In recent years, cancer immunotherapy has emerged as a promising approach where the patient's immune system is harnessed to fight cancer. One form of immunotherapy, called CAR-T-cell therapy, involves... Read more
New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
Preterm infants are particularly vulnerable due to their organs still undergoing development, which can lead to difficulties in breathing, eating, and regulating body temperature. This is especially true... Read more
Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
Endometrial cancer, which develops in the lining of the uterus, is the most prevalent gynecologic cancer in the United States, affecting over 66,000 women annually. Projections indicate that in 2025, around... Read moreMicrobiology
view channel
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read more
Rapid PCR Testing in ICU Improves Antibiotic Stewardship
A collaborative study led by the University of Plymouth (Devon, UK) has shown that rapid polymerase chain reaction (PCR) testing in the intensive care unit (ICU) improved antibiotic stewardship compared... Read morePathology
view channel
New Test Diagnoses High-Risk Childhood Brain Tumors
Medulloblastoma, which originates in the cerebellum, the rear part of the brain, is the most prevalent malignant brain tumor in children and is notoriously difficult to diagnose. Currently, identifying... Read more
Informatics Solution Elevates Laboratory Efficiency and Patient Care
QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories.... Read more
Microfluidic Device Assesses Stickiness of Tumor Cells to Predict Cancer Spread
Ductal carcinoma in situ (DCIS), a type of early-stage breast cancer, is often referred to as stage zero breast cancer. In many cases, it remains harmless and does not spread beyond the milk ducts where... Read more
New AI Tool Outperforms Previous Methods for Identifying Colorectal Cancer from Tissue Sample Analysis
Tissue analysis typically involves a pathologist reviewing scanned digital slides from a patient’s intestinal sample and marking specific areas, such as those where cancerous and related tissues are present.... Read moreTechnology
view channel
POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics
Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more
Study Explores Impact of POC Testing on Future of Diagnostics
In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more
Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer
Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read moreIndustry
view channel
CACLP 2025 Unites Global Innovators in IVD Industry
CACLP (Shanghai, China) will be holding the 22nd China International In Vitro Diagnostic Expo, the largest and most influential gathering of the IVD industry in China, 22-24 March 2025 at the Hangzhou... Read more
Bio-Rad to Acquire Digital PCR Developer Stilla Technologies
Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more